Archive Month: February 2023

The Verthermia® team conducted an FDA Phase 1 clinical trial during 2014-2015, resulting in significant findings on the positive impact […]

The image on the left shows the tumors at the beginning of the study. The image on the right shows […]

Ovarian Cancer Trial Result: No Decline in Daily Activities P=0.643 N=24 Over 24 cycles of HEATT® the mean Karnofsky: Performance […]

Expected and Actual Survival Months with Relative Failed Lines of Chemotherapy *patients who received no chemotherapy after HEATT®. [1] Hanker […]